Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2009 1
2010 3
2011 1
2012 1
2014 2
2015 2
2016 3
2018 1
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Functional Roles of Wilms’ Tumor 1 (WT1) in Malignant Brain Tumors.
Kijima N, Hashimoto N, Chiba Y, Fujimoto Y, Sugiyama H, Yoshimine T. Kijima N, et al. Among authors: chiba y. In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 15. In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 15. PMID: 27512757 Free Books & Documents. Review.
Six-month survival of a monochorionic monoamniotic twin with sirenomelia.
Hirata K, Yamamura-Miyazaki N, Kawaguchi H, Umeda S, Moon K, Chiba Y, Nishikawa M, Matsuoka K, Okamoto N. Hirata K, et al. Among authors: chiba y. Birth Defects Res. 2022 Nov 15;114(19):1286-1290. doi: 10.1002/bdr2.2016. Epub 2022 Apr 19. Birth Defects Res. 2022. PMID: 35437955
Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Yokota C, Kagawa N, Takano K, Chiba Y, Kinoshita M, Kijima N, Oji Y, Oka Y, Sugiyama H, Tsuboi A, Izumoto S, Kishima H, Hashimoto N. Yokota C, et al. Among authors: chiba y. Cancer Immunol Immunother. 2022 Jan;71(1):189-201. doi: 10.1007/s00262-021-02954-z. Epub 2021 Jun 5. Cancer Immunol Immunother. 2022. PMID: 34089373 Free PMC article.
A survey of disclosure of diagnosis to patients with glioma in Japan.
Yamamoto F, Hashimoto N, Kagawa N, Okita Y, Chiba Y, Kijima N, Kinoshita M, Yoshizu K, Fujimoto Y, Hirai K, Yoshimine T. Yamamoto F, et al. Among authors: chiba y. Int J Clin Oncol. 2011 Jun;16(3):230-7. doi: 10.1007/s10147-010-0152-8. Epub 2010 Dec 8. Int J Clin Oncol. 2011. PMID: 21136132
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies.
Yokota C, Nakata J, Takano K, Nakajima H, Hayashibara H, Minagawa H, Chiba Y, Hirayama R, Kijima N, Kinoshita M, Hashii Y, Tsuboi A, Oka Y, Oji Y, Kumanogoh A, Sugiyama H, Kagawa N, Kishima H. Yokota C, et al. Among authors: chiba y. Neurooncol Adv. 2021 Jun 29;3(1):vdab091. doi: 10.1093/noajnl/vdab091. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34355173 Free PMC article.
21 results